| Identification | More | [Name]
Metenolone | [CAS]
153-00-4 | [Synonyms]
1(5-ALPHA)-ANDROSTEN-1-BETA-METHYL-17-BETA-OL-3-ONE
1,5ALPHA-ANDROSTEN-1-METHYL-17BETA-OL-3-ONE
17beta-hydroxy-1-methyl-5alpha-androst-1-en-3-one
metenolone
METHENOLONE
MethenoloneAcetate434-05-9/Base
17b-Hydroxy-1-methyl-5a-androst-1-en-3-one
1-Methyl-D1-androsten-17b-ol-3-one
5a-Androst-1-en-3-one, 17b-hydroxy-1-methyl-(6CI, 7CI, 8CI)
Androst-1-en-3-one, 17-hydroxy-1-methyl-, (5a,17b)-(9CI)
Methenolone Base
17-Hydroxy-1,10,13-trimethyl-4,5,6,7,8,9,10,11,12,13, 14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one
5a-Androst-1-en-3-one, 17b-hydroxy-1-methyl-
Androst-1-en-3-one, 17-hydroxy-1-methyl-, (5a,17b)-
Metenolone Chemical | [EINECS(EC#)]
205-812-0 | [Molecular Formula]
C20H30O2 | [MDL Number]
MFCD00273128 | [Molecular Weight]
302.45 | [MOL File]
153-00-4.mol |
| Hazard Information | Back Directory | [Originator]
Primobolan ,Schering ,W. Germany,1961 | [Uses]
Methenolone is an anabolic steroid.
This is a controlled substance. | [Definition]
ChEBI: Methenolone is a 3-hydroxy steroid. It has a role as an androgen. | [Manufacturing Process]
8.42 ml of methyl iodide are slowly added dropwise at room temperature with
stirring in a nitrogen atmosphere to 3.067 g of magnesium turnings and 107
ml of absolute ether. After about 30 minutes, 185 ml of absolute
tetrahydrofuran are slowly introduced and then liquid is distilled off until a
boiling point of 62°C is reached. After cooling to room temperature, 613 mg
of cuprous chloride are added and then 10 g of ?1,4,6-androstatrien-17β-ol-3-
one-17-acetate in 110 ml of tetrahydrofuran slowly introduced. After 30
minutes reaction time, the whole is cooled to 0C, the excess of Grignard
reagent decomposed with saturated ammonium chloride solution, the product
diluted with ether and the aqueous phase separated. The ethereal phase is
washed consecutively with aqueous sodium thiosulfate solution, saturated
ammonium chloride solution and water. It is dried over sodium sulfate and
evaporated to dryness under vacuum. The residue is dissolved in 40 ml of
pyridine and 20 ml of acetic anhydride and the solution kept for 16 hours at
room temperature. It is then stirred into ice water and the precipitate filtered
with suction, dried and recrystallized from isopropyl ether. 1α-Methyl-?4,6-
androstadien-17β-ol-3-one-17-acetate is obtained. MP 156°C to 157°C; [α]D25
= -33.8° (in CHCl3; c = 0.9). Yield 65-70% of the theoretical.
4.67 g of 1α-methyl-?4,6-androstadien-17β-ol-3-one-17-acetate are dissolved
in 273 ml of methanol and, after the addition of 350 mg of 10% palladium on
calcium carbonate catalyst, hydrogenated until 1 mol equivalent of hydrogen
has been taken up. After filtering off the catalyst, the solution is treated with
150 ml of 2N-hydrochloric acid and evaporated under vacuum to about 1/3 of
the volume. The whole is then diluted with water and extracted with ether.
The ethereal solution is washed with water until neutral, dried over sodium
sulfate and evaporated. The crude product is heated on a steam bath for 90
minutes in 10 ml of pyridine and 10 ml of acetic anhydride. Extraction with
ether is then carried out and the ethereal phase washed until neutral with
water. The crude crystalline 1α-methyl-?4-androsten-17β-ol-3-one-17-
acetateobtained after drying and evaporation of the solution, melts at 122°C
to 129°C. Yield 98% of the theoretical.
1α-Methyl-?4-androsten-17β-ol-3-one-17-acetate when purified by
recrystallization from isopropyl ether melts at 138°C to 139°C. | [Therapeutic Function]
17β-Hydroxy-1β-methyl-5α-androst-l-ene-3-one acetate |
|
|